Published guidance, NICE advice and quality standards | Guidance

Showing 261 to 270 of 302

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer	TA214	23 February 2011	23 February 2011
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer	TA212	15 December 2010	15 December 2010
Percutaneous radiofrequency ablation for primary or secondary lung cancers	IPG372	15 December 2010	15 December 2010
Trastuzumab for the treatment of HER2-positive metastatic gastric cancer	TA208	24 November 2010	24 November 2010
Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer	IPG356	22 September 2010	22 September 2010
Capecitabine for the treatment of advanced gastric cancer	TA191	28 July 2010	28 July 2010
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer	TA192	28 July 2010	28 July 2010
Percutaneous radiofrequency ablation for renal cancer	IPG353	28 July 2010	28 July 2010
Topotecan for the treatment of relapsed small-cell lung cancer	TA184	25 November 2009	25 November 2009
Topotecan for the treatment of recurrent and stage IVB cervical cancer	TA183	28 October 2009	28 October 2009